PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Net income 2016–2025
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$5.5MFY2025 · since FY2016: -$24.4M → $5.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.5M | +15.6% |
| FY2024 | $4.8M | +53.5% |
| FY2023 | $3.1M | +187.3% |
| FY2022 | -$3.6M | +35.8% |
| FY2021 | -$5.5M | +17.0% |
| FY2020 | -$6.7M | +3.5% |
| FY2019 | -$6.9M | +15.1% |
| FY2018 | -$8.2M | +39.7% |
| FY2017 | -$13.5M | +44.7% |
| FY2016 | -$24.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice